Immunotherapy benefits relapsed stem cell transplant recipients Dana-Farber Cancer Institute – EurekAlert (press release)
|
Immunotherapy benefits relapsed stem cell transplant recipients Dana-Farber Cancer Institute
EurekAlert (press release) BOSTON — For many patients with advanced blood cancers, a stem–cell transplant can drive the disease into remission. However, about one-third of these patients experience a relapse and face a very poor prognosis. But a Dana-Farber Cancer Institute … |
